Please wait a minute...
文章检索
预防医学  2024, Vol. 36 Issue (8): 731-736    DOI: 10.19485/j.cnki.issn2096-5087.2024.08.020
  实验技术 本期目录 | 过刊浏览 | 高级检索 |
五味苦参肠溶胶囊对溃疡性结肠炎大鼠肠道菌群的影响
胡珂杰, 熊加彬, 吴俊俊, 李珍, 朱伟琴, 李华铭
杭州市第三人民医院消化内科,浙江 杭州 310000
Effect of five-flavor Sophora falvescens enteric-coated capsules on intestinal flora in rats with ulcerative colitis
HU Kejie, XIONG Jiabin, WU Junjun, LI Zhen, ZHU Weiqin, LI Huaming
Department of Gastroenterology, Hangzhou Third People's Hospital, Hangzhou, Zhejiang 310000, China
全文: PDF(1035 KB)  
输出: BibTeX | EndNote (RIS)      
摘要 目的 探讨五味苦参肠溶胶囊对溃疡性结肠炎(UC)大鼠肠道菌群的影响,为五味苦参肠溶胶囊治疗UC的作用机制研究提供参考。方法 40只SPF级Wistar大鼠随机分为对照组、模型组、美沙拉嗪组和五味苦参肠溶胶囊组,除对照组外,其他3组饮用3%葡聚糖硫酸钠7 d建立UC模型。造模成功后,对照组、模型组大鼠予2 mL/kg体重0.9%氯化钠溶液灌胃,美沙拉嗪组大鼠予2 mL/kg体重美沙拉嗪悬浊液(0.2 g/kg)灌胃,五味苦参肠溶胶囊组大鼠予2 mL/kg体重五味苦参肠溶胶囊药物颗粒悬浊液(2.16 g/kg)灌胃,连续2周。取大鼠结肠组织,采用苏木精-伊红染色观察大鼠结肠组织病理学改变;收集大鼠粪便,对肠道菌群进行16S rDNA高通量测序和生物学信息分析,比较各组大鼠肠道菌群α和β多样性,采用LEfSe分析法筛选各组优势菌群。结果 与对照组比较,模型组大鼠结肠组织隐窝大量缺失,大量炎性细胞浸润;与模型组比较,美沙拉嗪组、五味苦参肠溶胶囊组大鼠结肠组织隐窝少量缺失,少量或无炎性细胞浸润,组织损伤改善。α多样性分析结果显示,与对照组比较,模型组Chao1、Shannon指数升高,Simpson指数降低;与模型组比较,美沙拉嗪组、五味参苦参肠溶胶囊组Chao1、Shannon指数降低,Simpson指数升高(均P<0.05)。β多样性分析结果显示,五味苦参肠溶胶囊组与对照组样本距离小于模型组与对照组样本距离。LEfSe分析结果显示,模型组优势菌群主要为另枝菌属、颤螺菌属;五味苦参肠溶胶囊组优势菌群为瘤胃球菌属、普雷沃菌属。结论 五味苦参肠溶胶囊可改善肠道菌群结构,增加瘤胃球菌属、普雷沃菌属等有益菌丰度,降低另枝菌属等致病菌丰度,缓解UC大鼠的炎症反应。
服务
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章
胡珂杰
熊加彬
吴俊俊
李珍
朱伟琴
李华铭
关键词 溃疡性结肠炎肠道菌群五味苦参肠溶胶囊16S rDNA高通量测序    
AbstractObjective To explore the impact of five-flavor Sophora flavescens enteric-coated capsules (FSEC) on the intestinal flora of rats with ulcerative colitis (UC), so as to provide the reference for the mechanism of FSEC in treating UC. Methods Forty SPF-grade Wistar rats were randomly divided into the control group, the model group, the mesalazine group and the FSEC group. Except the control group (0.9% sodium chloride solution), the other 3 groups used 3% dextran sulfate sodium (DSS) for 7 days to establish UC model. After successful modeling, the control group and the model group were given 2 mL/kgbw of 0.9% sodium chloride solution by gavage for 2 weeks, while the mesalazine group and the FSEC group were given 2 mL/kgbw of mesalazine suspension (0.2 g/kg) and FSEC granule suspension (2.16 g/kg), respectively. Pathological changes of colon tissue were observed after hematoxylin-eosin (HE) staining. Rat fecal samples were collected, and 16S rDNA high-throughput sequencing and bioinformatics analysis were performed on intestinal flora. The α and β diversity of intestinal flora among the four groups were compared, and the dominant flora was screened using LEfSe analysis. Results Compared with the control group, the model group showed a significant loss of colonic crypts and a large infiltration of inflammatory cells. Compared with the model group, the mesalazine group and the FSEC group exhibited a slight loss of colonic crypts, a small amount or an absence inflammatory cell infiltration, and improved tissue damage. The α-diversity analysis showed that compared with the control group, the Chao1 and Shannon indices in the model group increased, while the Simpson index decreased; compared with the model group, the Chao1 and Shannon indices in the mesalazine group and the FSEC group decreased, and the Simpson index increased(all P<0.05). The β-diversity analysis showed that the sample distance between the FSEC group and the control group were more closer than that between the model group and the control group. LEfSe analysis results showed that the dominant bacteria in the model group were mainly from the Alistipes and Oscillospira. In the FSEC group, the dominant bacteria were from the Ruminococcus and Prevotella. Conclusion FSEC can improve the structures of intestinal flora, increase the abundance of beneficial bacteria such as Ruminococcus and Prevotella, reduce the abundance of pathogenic bacteria such as Alistipes, and alleviate the inflammatory response in UC rats.
Key wordsulcerative colitis    intestinal flora    five-flavor Sophora falvescens enteric-coated capsules    16S rDNA high-throughput sequencing
收稿日期: 2024-05-13      修回日期: 2024-08-02      出版日期: 2024-08-10
中图分类号:  R285.5  
基金资助:浙江省中医药科技计划项目(2022ZA138)
作者简介: 胡珂杰,本科,主治医师,主要从事临床医学工作
通信作者: 李华铭,E-mail:lhm133433@163.com   
引用本文:   
胡珂杰, 熊加彬, 吴俊俊, 李珍, 朱伟琴, 李华铭. 五味苦参肠溶胶囊对溃疡性结肠炎大鼠肠道菌群的影响[J]. 预防医学, 2024, 36(8): 731-736.
HU Kejie, XIONG Jiabin, WU Junjun, LI Zhen, ZHU Weiqin, LI Huaming. Effect of five-flavor Sophora falvescens enteric-coated capsules on intestinal flora in rats with ulcerative colitis. Preventive Medicine, 2024, 36(8): 731-736.
链接本文:  
http://www.zjyfyxzz.com/CN/10.19485/j.cnki.issn2096-5087.2024.08.020      或      http://www.zjyfyxzz.com/CN/Y2024/V36/I8/731
[1] SHOU X T,WANG Y M,ZHANG X S,et al.Network pharmacology and molecular docking analysis on molecular mechanism of Qingzi Zhitong decoction in the treatment of ulcerative colitis[J/OL].Front Pharmacol,2022,[2024-08-02].https://doi.org/10.3389/fphar.2022.727608.
[2] 缪志伟,徐艳,宁丽琴,等.白头翁汤治疗溃疡性结肠炎分子机制的网络药理学分析及初步验证[J].中国中药杂志,2020,45(8):1808-1815.
[3] WU Y,RAN L,YANG Y,et al.Deferasirox alleviates DSS-induced ulcerative colitis in mice by inhibiting ferroptosis and improving intestinal microbiota[J/OL].Life Sci,2023[2024-08-02].https://doi.org/10.1016/j.lfs.2022.121312.
[4] 徐磊,沈雁,钟继红,等.姜黄素对溃疡性结肠炎小鼠结肠组织病变及细胞因子表达水平的影响[J].预防医学,2019,31(4):381-384,389.
[5] 吴军城,赵立国,张立文.灯盏花乙素调节AMPK/SIRT1/PGC-1ɑ信号通路对溃疡性结肠炎大鼠肠道菌群的影响[J].中国病原生物学杂志,2024,19(1):36-41.
[6] 李先先,冯文哲,肖刚.四神丸治疗溃疡性结肠炎的研究进展[J/OL].辽宁中医药大学学报,2024[2024-08-02].https://link.cnki.net/urlid/21.1543.R.20240513.1506.012.
[7] 刁凌云,王胜英,皇金萍,等.美沙拉秦缓释颗粒剂联合五味苦参肠溶胶囊治疗溃疡性结肠炎的疗效观察[J].包头医学院学报,2021,37(10):43-48.
[8] TONG Z Q,YANG B,CHEN B Y,et al.A multi-center,randomized,single-blind,controlled clinical study on the efficacy of composite sophora colon-soluble capsules in treating ulcerative colitis[J].Chin J Integr Med,2010,16(6):486-492.
[9] 任天宇,韩谨泽,刘潼,等.参苓白术散药味增减对溃疡性结肠炎模型小鼠的治疗效果[J].黑龙江畜牧兽医,2024(2):105-110.
[10] HAN Y Y,LIU L Y,CHEN Y Q,et al.Qing Hua Chang Yin alleviates chronic colitis of mice by protecting intestinal barrier function and improving colonic microflora[J/OL].Front Pharmacol,2023[2024-08-02].https://doi.org/10.3389/fphar.2023.1176579.
[11] 朱阳青. 五味苦参肠胶囊治疗溃疡性结肠炎的系统评价与网络药理学分析[D].宜春:宜春学院,2022.
[12] 陈杨,施丽婕,刘雷蕾,等.基于16S rDNA测序研究化瘀通阳方对溃疡性结肠炎大鼠肠道菌群的影响[J].中华中医药杂志,2020,35(2):941-946.
[13] 鲍炳州,朱超,吴生兵,等.基于16S rDNA测序技术探索白头翁汤灌肠对湿热型溃疡性结肠炎大鼠肠道菌群的影响[J].安徽中医药大学学报,2019,38(6):62-68.
[14] 王钰,褚福浩,程思怡,等.慢痞消组方中药对嗜黏蛋白阿克曼菌、大肠杆菌和粪肠球菌的增殖影响及药效规律初探[J].吉林中医药,2023,43(12):1449-1453.
[15] 姜慧,丁庞华,路琼琼,等.基于16S rDNA高通量测序技术的活动期溃疡性结肠炎大肠湿热证患者舌苔菌群多样性研究[J].中华中医药杂志,2022,37(6):3484-3488.
[16] PARKER B J,WEARSCH P A,VELOO A C M,et al.The genus Alistipes:gut bacteria with emerging implications to inflammation,cancer,and mental health[J/OL].Front Immunol,2020[2024-08-02].https://doi.org/10.3389/fimmu.2020.00906.
[17] YANG J P,LI Y N,WEN Z Q,et al.Oscillospira-a candidate for the next-generation probiotics[J].Gut Microbes,2021,13(1):1-18.
[18] 王小康,朱晓芳.银屑病患者与健康人肠道菌群的差异研究[J].中国现代医药杂志,2023,25(3):37-41.
[19] 梁露莹,林鸿鑫,蔡义思,等.基于16S rDNA测序研究当归拈痛汤对风湿热痹佐剂性关节炎大鼠肠道菌群的影响[J].中国实验方剂学杂志,2023,29(9):18-27.
[1] 陈颖, 刘可, 刘彬, 孙晓慧, 何志兴, 毛盈颖, 叶丁. 肠道菌群与多囊卵巢综合征的孟德尔随机化研究[J]. 预防医学, 2024, 36(9): 801-805.
[2] 高菡璐, 俞晓芳, 吕乐彬, 叶国良, 樊金卿. 多靶点粪便DNA、肠道菌群、癌胚抗原及水果摄入对结直肠癌风险的交互作用研究[J]. 预防医学, 2024, 36(3): 219-223.
[3] 徐军, 徐涯鑫, 高亚南, 姚亭, 孙素亚, 陈亚梅. 溃疡性结肠炎与胰腺炎的孟德尔随机化研究[J]. 预防医学, 2024, 36(1): 26-29, 33.
[4] 王冬, 陈基快, 蔡文杰, 陈岳涛, 蒋春燕, 郁小红. 飞行人员高脂血症与肠道菌群分布研究[J]. 预防医学, 2022, 34(7): 665-671.
[5] 张泽鹏, 郭展鹏, 倪钰玥, 富灿涯, 朱梦瑶, 付莹婕, 裘迪红. 植物乳杆菌JX025073.1对小鼠血脂和肠道菌群的调节作用[J]. 预防医学, 2021, 33(9): 893-896.
[6] 都文渊, 苏书贞, 赵玉斌, 郭新娥, 张哲, 姚建景, 王淑玲. 八段锦改善老年人平衡能力和肠道菌群效果评价[J]. 预防医学, 2020, 32(4): 425-428.
[7] 赵晨飞, 朱明利, 师金川, 喻剑华. 艾滋病抗病毒治疗对HIV-1感染者肠道微生态的影响[J]. 预防医学, 2020, 32(3): 274-278.
[8] 徐磊, 沈雁, 钟继红, 王章流, 郑华君, 许国富. 姜黄素对溃疡性结肠炎小鼠结肠组织病变及细胞因子表达水平的影响[J]. 预防医学, 2019, 31(4): 381-384,389.
[9] 周雪峰,陆其明. 微生态制剂治疗缺血性肠炎的疗效观察[J]. 预防医学, 2017, 29(12): 1256-1257.
[10] 沈雁, 李思, 钟继红, 徐磊, 王章流, 郑华君. 小檗碱对溃疡性结肠炎小鼠结肠组织紧密连接蛋白claudin-1表达的影响[J]. 预防医学, 2017, 29(11): 1098-1103.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed